These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37725712)

  • 1. Scirrhous HCC: Another 'omic thread in the HCC tapestry.
    Franses JW; Duda DG
    Hepatology; 2024 Apr; 79(4):747-748. PubMed ID: 37725712
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes of Patients with Scirrhous Hepatocellular Carcinoma: Insights from the National Cancer Database.
    Farooq A; Merath K; Paredes AZ; Wu L; Tsilimigras DI; Hyer JM; Sahara K; Mehta R; Beal EW; Pawlik TM
    J Gastrointest Surg; 2020 May; 24(5):1049-1060. PubMed ID: 31243715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma.
    Huang SC; Liao SH; Su TH; Jeng YM; Kao JH
    Hepatol Int; 2021 Apr; 15(2):472-481. PubMed ID: 33544314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY; Kim SH; Lee WJ; Lim HK
    Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection.
    Kim SH; Lim HK; Lee WJ; Choi D; Park CK
    Eur J Radiol; 2009 Jan; 69(1):123-30. PubMed ID: 17976942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches.
    Dhanasekaran R
    Semin Liver Dis; 2021 Jan; 41(1):9-18. PubMed ID: 33764481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history and treatment trends in hepatocellular carcinoma subtypes: Insights from a national cancer registry.
    Jernigan PL; Wima K; Hanseman DJ; Hoehn RS; Ahmad SA; Shah SA; Abbott DE
    J Surg Oncol; 2015 Dec; 112(8):872-6. PubMed ID: 26603598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minute scirrhous hepatocellular carcinomas undergoing different carcinogenetic processes.
    Fujii T; Zen Y; Nakanuma Y
    Pathol Int; 2007 Jul; 57(7):443-8. PubMed ID: 17587244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1.
    Matsuura S; Aishima S; Taguchi K; Asayama Y; Terashi T; Honda H; Tsuneyoshi M
    Histopathology; 2005 Oct; 47(4):382-90. PubMed ID: 16178893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric metastasis of hepatocellular carcinoma via a possible existing retrograde hematogenous pathway.
    Hu ML; Tai WC; Chuah SK; Chiu YC; Wu KL; Chou YP; Kuo CM; Hu TH; Chiu KW
    J Gastroenterol Hepatol; 2010 Feb; 25(2):408-12. PubMed ID: 19929932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma with direct invasion to the stomach.
    Inoue H; Sawada Y; Ochiai K; Honda H; Murayama J; Kudo Y; Nakashima Y; Sagihara N; Miyatani H; Nakamura I; Yoshida Y
    Intern Med; 2007; 46(12):845-8. PubMed ID: 17575376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis and selection of treatment modalities for hepatocellular carcinoma].
    Okamura J; Monden M; Sakon M; Mori T; Kuroda C; Sakurai M
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):203-9. PubMed ID: 3004362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma.
    Marrero JA; Pelletier S
    Clin Liver Dis; 2006 May; 10(2):339-51, ix. PubMed ID: 16971265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine.
    Gong Y
    Chin J Integr Med; 2012 Apr; 18(4):245-9. PubMed ID: 22457133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on hepatocellular carcinoma: Pathologists' review.
    El Jabbour T; Lagana SM; Lee H
    World J Gastroenterol; 2019 Apr; 25(14):1653-1665. PubMed ID: 31011252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multidisciplinary treatment for hepatocellular carcinoma invading the stomach].
    Takahashi M; Beppu T; Doi K; Ishiko T; Kai K; Doi Y; Okabe H; Egami H; Ashihara H; Fujiyama S; Ogawa M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1741-4. PubMed ID: 14619508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastric metastasis of hepatocellular carcinoma treated by transarterial chemoembolization: a case report].
    Kim JH; Park JW; Choi JI; Kim HB; Koh DW; Lee WJ; Kim CM
    Korean J Hepatol; 2007 Mar; 13(1):91-5. PubMed ID: 17380079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary Team Management of Hepatocellular Carcinoma Is Standard of Care.
    Lhewa D; Green EW; Naugler WE
    Clin Liver Dis; 2020 Nov; 24(4):771-787. PubMed ID: 33012458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma exchange for malignant neoplasms--immunological consideration].
    Maeda K; Matsumoto S; Ito N; Takeuchi S; Omi N
    Rinsho Ketsueki; 1982 Oct; 23(10):1608-12. PubMed ID: 6296481
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical treatments for hepatocellular carcinoma (HCC): what's next?
    Taieb J; Barbare JC; Rougier P
    Ann Oncol; 2006 Sep; 17 Suppl 10():x308-14. PubMed ID: 17018744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.